首页> 外国专利> Extracellular vesicle secretory inhibitor suppressing prostate endothelium secretion from prostate cancer cells, therapeutic agent for prostate cancer, and use thereof

Extracellular vesicle secretory inhibitor suppressing prostate endothelium secretion from prostate cancer cells, therapeutic agent for prostate cancer, and use thereof

机译:细胞外囊泡分泌抑制剂抑制前列腺癌细胞,前列腺癌治疗剂的前列腺内皮分泌物,及其用途

摘要

Problem to be solved: to provide new drugs leading to the treatment of prostate cancer.The extracellular vesicle secretory inhibitor of the present invention is an extracellular vesicle secreting inhibitor that suppresses the secretion of extracellular vesicles from prostate cancer cells, and hh4, PFDN4, chalcod1, NSD1 The present invention is characterized in that there is a suppressive substance that suppresses the expression or function of at least one protein selected from the group consisting of SRM.The prostatic cancer therapeutic agent of the present invention is characterized by comprising an extracellular vesicle secreting inhibitor of the present invention.Diagram
机译:要解决的问题:提供新药,导致治疗前列腺癌。本发明的细胞外囊泡分泌抑制剂是细胞外囊泡分泌抑制剂,其抑制来自前列腺癌细胞的细胞外囊和HH4,PFDN4,Chalcod1的细胞外囊泡分泌抑制剂 ,NSD1本发明的特征在于存在抑制物质,其抑制选自Srm的至少一种蛋白质的表达或功能。本发明的前列腺癌治疗剂的特征在于包含细胞外囊泡分泌物 本发明的抑制剂.Diagram

著录项

  • 公开/公告号JP2021138623A

    专利类型

  • 公开/公告日2021-09-16

    原文格式PDF

  • 申请/专利权人 テオリアサイエンス株式会社;

    申请/专利号JP20200035342

  • 发明设计人 落谷 孝広;占部 文彦;小坂 展慶;

    申请日2020-03-02

  • 分类号A61K45;G01N33/50;G01N33/15;A61P35;A61P43;A61K38/02;A61K48;A61K31/7105;A61K31/713;A61K39/395;C12N15/113;C07K16/32;C12N15/63;

  • 国家 JP

  • 入库时间 2022-08-24 21:06:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号